Adaptive Biotechnologies ...
(ADPT)
undefined
undefined%
At close: undefined
6.30
0.08%
After-hours Dec 13, 2024, 06:08 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Revenue | 170.28M | 185.31M | 154.34M | 98.38M | 85.07M | 55.66M | 38.45M |
Cost of Revenue | 75.55M | 57.91M | 49.30M | 22.53M | 22.27M | 19.67M | 15.68M |
Gross Profit | 94.72M | 127.40M | 105.04M | 75.85M | 62.80M | 35.99M | 22.77M |
Operating Income | -227.03M | -200.19M | -208.97M | -152.82M | -78.39M | -49.76M | -44.48M |
Interest Income | 15.53M | 4.06M | 1.67M | 6.59M | 9.79M | 3.31M | 1.64M |
Pretax Income | -225.30M | -200.37M | -207.30M | -146.23M | -68.61M | -46.45M | -42.83M |
Net Income | -225.25M | -142.46M | -205.61M | -139.64M | -58.82M | -46.45M | -42.83M |
Selling & General & Admin | 172.51M | 184.13M | 169.97M | 110.89M | 68.78M | 44.90M | 32.71M |
Research & Development | 122.12M | 141.76M | 142.34M | 116.07M | 70.70M | 39.16M | 32.00M |
Other Expenses | 27.13M | 1.70M | 1.70M | 1.70M | 1.70M | 1.70M | 1.69M |
Operating Expenses | 321.76M | 327.58M | 314.01M | 228.67M | 141.19M | 85.75M | 66.40M |
Interest Expense | 13.80M | 4.24M | - | - | - | - | - |
Selling & Marketing Expenses | 88.58M | 95.60M | 95.47M | 61.36M | 38.45M | 24.49M | 16.77M |
Cost & Expenses | 397.31M | 385.49M | 363.31M | 251.20M | 163.46M | 105.42M | 82.08M |
Income Tax | - | -57.90M | -1.69M | -6.59M | -9.79M | 3.31M | -804.00K |
Shares Outstanding (Basic) | 144.38M | 142.52M | 140.35M | 131.22M | 69.17M | 105.43M | 105.43M |
Shares Outstanding (Diluted) | 144.38M | 142.52M | 140.35M | 131.22M | 69.17M | 105.43M | 105.43M |
EPS (Basic) | -1.56 | -1 | -1.46 | -1.06 | -0.85 | -0.44 | -0.41 |
EPS (Diluted) | -1.56 | -1 | -1.46 | -1.06 | -0.85 | -0.44 | -0.41 |
EBITDA | -189.27M | -167.98M | -193.34M | -144.34M | -70.60M | -43.76M | -37.84M |
Depreciation & Amortization | 22.23M | 28.15M | 20.98M | 11.74M | 7.79M | 6.00M | 5.80M |